New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For AAPL;HMY;MRK;BAC From The Last 14 Days
Check below for free stories on AAPL;HMY;MRK;BAC the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>
April 23, 2014
18:25 EDTAAPLApple planning for annual divided increases 'going forward'
Subscribe for More Information
18:24 EDTAAPLApple has sold more than 20M Apple TV set-top boxes
Subscribe for More Information
18:08 EDTAAPLApple iPhone ASPs were down $41 in Q2 in part from stronger 4S sales
Regarding the decline in ASPs or 'average selling price' on the iPhone, Apple said on its Q2 earnings call: "When you look at the $41 of decline, I would say about half of that was driven by the fact that we have continued to do very well in emerging markets with the 4S. I mentioned that there's a lot of markets where we've grown very strongly, in Latin America, in Asia-Pacific, in Eastern Europe. So about half of that decline came from the stronger sales of the 4S. And then the rest was primarily the fact that, again, as we move away from the quarter where we launch the product, we tend to have lower capacity mix in our numbers."
17:59 EDTAAPLApple has done 24 acquisitions in 18 months
Subscribe for More Information
17:51 EDTAAPLApple says 'current stock price doesn't reflect full value of the company'
Subscribe for More Information
17:46 EDTAAPLApple China revenue for Q2 a record for company at almost $10B
Subscribe for More Information
17:42 EDTAAPLApple iPad sales came in at the high end of the companyís expectations
Subscribe for More Information
17:38 EDTAAPLApple now has nearly 800M iTunes accounts
Comment from Q2 earnings conference call.
17:05 EDTAAPLIcahn still sees Apple as 'meaningfully undervalued'
Icahn comments on Twitter. Reference Link
16:57 EDTAAPLCarl Icahn says 'extremely pleased' with Apple results
Subscribe for More Information
16:46 EDTAAPLApple resumes trading, shares up 8%, or $39.56, to $564.31
Subscribe for More Information
16:39 EDTAAPLApple announces seven-for-one split, boosts dividend, buyback
Subscribe for More Information
16:35 EDTAAPLApple sold 43.7M iPhones in Q2 vs. 51.03M last quarter
Apple sold 16.35M iPads in Q2 vs. 26.04M last year. Sold 4.14M Macs vs. 4.84M Macs last quarter. Sold 2.76M iPods vs. 6.05M last quarter.
16:33 EDTAAPLApple boosts quarterly dividend by 8% to $3.29
Subscribe for More Information
16:32 EDTAAPLApple raises share repurchase authorization to $90B from $60B
Subscribe for More Information
16:32 EDTAAPLApple announces seven-for-one stock split
16:31 EDTAAPLApple raises capital return program to over $130B
Subscribe for More Information
16:31 EDTAAPLApple sees Q3 revenue $36B-$38B, consensus $37.87B
Sees Q3 gross margin 37%-38%.
16:30 EDTAAPLApple reports Q2 EPS $11.62, consensus $10.18
Reports Q2 revenue $45.6B, consensus $43.53B.
16:29 EDTAAPLApple trading halted, pending news
Subscribe for More Information
15:41 EDTAAPLNotable companies reporting after market close
Subscribe for More Information
15:20 EDTAAPLEarnings Preview: Qualcomm mentioned positively by firms throughout April
Subscribe for More Information
14:18 EDTAAPLEarnings Preview: iPhone sales in focus ahead of Apple's Q2 report
Subscribe for More Information
14:04 EDTAAPLApple April weekly 525 straddle priced for 3.7% move into Q2
13:46 EDTAAPLApple technical comments ahead of earnings
Subscribe for More Information
09:34 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GILD NFLX TSLA VZ MU WFM AMGN
08:10 EDTAAPLGoogle took on some Samsung liability in fight with Apple, Re/code says
Subscribe for More Information
07:34 EDTAAPLApple April weekly volatility elevated at 64 into Q2
Subscribe for More Information
06:54 EDTMRKCambridge Healthtech Institute to hold a conference
Subscribe for More Information
06:54 EDTMRKGlobal Technology Community to hold a summit
7th Annual Diabetes Summit is being held in Cambridge, MA on April 23-25.
06:16 EDTMRKPharmaceutical companies narrowing focus, WSJ reports
Subscribe for More Information
April 22, 2014
18:42 EDTAAPLIcahn reiterates hasn't sold a share of Apple
Icahn speaks in online interview with CNBC's David Faber.
16:04 EDTAAPLOptions Update; April 22, 2014
Subscribe for More Information
14:06 EDTAAPLApple's large screen phone may not emerge until 2015, Cnet reports
Subscribe for More Information
13:18 EDTAAPLOpera says Android overtook iOS in mobile ad traffic
Subscribe for More Information
12:39 EDTMRKOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday amid a number of big deals and a much talked about proposed deal in the pharmaceutical industry, as well as another wave of earnings reports. The market opened quietly but on the positive side of the ledger as investors pored over the multitude of quarterly reports issued after the close last night and earlier today. Near noon the market stood near its session highs and is pointing toward its sixth consecutive positive close. ECONOMIC EVENTS: In the U.S., existing home sales slipped 0.2% to a 4.59M rate in March, versus expectation for them to have fallen 1% to a 4.56M rate. The Richmond Fed manufacturing survey for April had a reading of 7, beating the consensus forecast for a reading of 2. COMPANY NEWS: Valeant Pharmaceuticals (VRX) teamed with Bill Ackman's hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), sending shares of both companies higher. Allergan confirmed it received the offer of $48.30 in cash and 0.83 shares of Valeant stock for each of its own shares, which it said it will evaluate with the help of its advisers. Analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover of Shire (SHPG) or Jazz Pharmaceuticals (JAZZ) as a defense, and another saying a rival big pharma company, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan. Shares of Allergan led all gainers on the S&P 500, rising 16%, while Valeant shares gained more than 6%... A number of other big drug makers made news with a string of deals, as Novartis (NVS) and GlaxoSmithKline (GSK) both reshaped their companies via a trio of agreements. Novartis will acquire GSK's oncology products for a $14.5B payment and up to $1.5B contingent future payments, Novartis will sells its Vaccines business, excluding flu, to GSK for $7.1B plus royalties, and the two agreed to tie-up their consumer healthcare businesses through a joint venture. In a separate transaction, Novartis agreed to divest its Animal Health Division to Eli Lilly (LLY) for about $5.4B. MAJOR MOVERS: Among the notable gainers following their earnings reports were streaming video service Netflix (NFLX), which advanced almost 6%, and motorcycle maker Harley-Davidson (HOG), which rose 8%. Companies that slid following their earnings reports included printer maker Lexmark (LXK), which fell over 11%, and Pentair (PNR), which dropped almost 6%. INDEXES: Near midday, the Dow was up 106.77, or 0.65%, to 16,556.02, the Nasdaq was up 45.95, or 1.11%, to 4,167.50, and the S&P 500 was up 11.59, or 0.62%, to 1,883.48.
11:22 EDTMRKAnalysts think Valeant bid for Allergan could spur higher offer, rival deal
After Valeant Pharmaceuticals (VRX) teamed with hedge fund Pershing Square to make a hostile takeover offer for Allergan (AGN), analysts' opinion on the fallout varied, with one firm suggesting Allergan could pursue its own takeover as a defense and another believing Valeant will be pushed to raise its offer. WHAT'S NEW: Valeant, in partnership with Bill Ackman's Pershing Square, offered to combine with Allergan for $48.30 in cash and 0.83 shares of Valeant stock for each share of Allergan. Allergan has confirmed it received the offer and said that it would evaluate the proposal. ANALYST OPINION: In a note to investors, Wells Fargo stated that it believes that Valeant's low tax rate will enable it to raise its bid. Moreover, one or more big pharmaceutical companies, such as Johnson & Johnson (JNJ) or Merck (MRK), could launch a competing bid for Allergan, added Wells. The firm believes that Allergan could ultimately be purchased for $165 per share. Research firm Jefferies said it expects Allergan's board to oppose Valeant's takeover attempt. The firm suggested that Allergan could seek to fend off Valeant's takeover attempt by acquiring Shire (SHPG) or Jazz Pharmaceuticals (JAZZ). Jefferies kept a Hold rating on Allergan. BMO Capital similarly believes that Valeant will have to overcome significant hurdles in order to complete the deal. The management teams of the two companies have different views and Allergan's business could be damaged by significant cost cutting following the deal, according to the firm. Nonetheless, it kept an Outperform rating on the Botox maker. PRICE ACTION: In mid-morning trading, Allergan rallied 15.5% to $164, Valeant gained 4.4% to $133, Jazz shares rose 6.4% to $147.18 and Shire added 4.8% to $158.62.
09:38 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:26 EDTBACInformation Management Network to hold a conference
Subscribe for More Information
07:24 EDTBACSourceMedia to hold a forum
26th Annual Card Forum & Expo is being held in Orlando on April 22-25.
07:16 EDTAAPLiPhone sales could be hurt by fading phone subsidies, WSJ reports
Sales of Apple's (AAPL) iPhones may be further pressured as carriers make faster progress in transitioning customers away from subsidies, the Wall Street Journal reports. U.S. wireless carriers like T-Mobile US (TMUS) and AT&T (T) have been having more success than expected in moving customers to non-subsidy plans, a transition that could harm sales of expensive handsets such as the iPhone. Reference Link
06:42 EDTAAPLSamsung thinks $2.19B too costly for Apple patents, Bloomberg says
Samsung (SSNLF) feels that Apple's (AAPL) patent-infringement lawsuit of $2.19B is 57 times greater than what the South Korean company should pay if a jury deems that it infringed smartphone technology, reported Bloomberg. Reference Link
06:19 EDTBACInvestment banks battling over stock trading, WSJ reports
Subscribe for More Information
06:11 EDTMRKWells says big pharma bidders could emerge for Allergan
Wells Fargo believes Allergan (AGN) wants to remain independent and says the "hurdle to convince the company to sell could be pretty high." Wells thinks Valeant's (VRX) low tax rate gives it room to raise its bid for Allergan, and it sees the potential for one or more big pharma bidders, such as Johnson & Johnson (JNJ) or Merck (MRK), emerging due to Allergan's "attractive eye care and aesthetics portfolio and pipeline." Wells believes a purchase price for Allergan of $50B or $165 per share could be justified.
April 21, 2014
16:01 EDTAAPLOptions Update; April 21, 2014
iPath S&P 500 VIX Short-Term Futures down 78c to 40.03. Option volume leaders: AAPL C GILD NFLX TSLA TWTR FB WLT according to Track Data.
15:05 EDTAAPLApple recruiting employees for mobile payments, Re/code says
Subscribe for More Information
14:40 EDTAAPLWi-LAN files appeal in patent suit with Apple
Wi-LAN (WILN) announced that it has filed an appeal with the United States Court of Appeals for the Federal Circuit in its patent dispute with Apple (AAPL) involving WiLAN's U.S. Patent No. RE37,802. On April 3, Judge Rodney Gilstrap of the U.S. District Court for the Eastern District of Texas, ruled that the Jury had no basis for invalidating the 802 patent at the trial of the WiLAN vs. Apple lawsuit in October 2013. In addition to this case, WiLAN is in litigation with Apple in the Southern District of California concerning the infringement of two patents related to LTE technology. WiLAN expects the case in Southern California to go to trial later this year if not settled earlier.
11:34 EDTAAPLApple April weekly volatility elevated at 50 into Q2
Subscribe for More Information
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
09:32 EDTAAPLJabil Circuit downgraded at RBC Capital
As noted earlier, RBC Capital downgraded Jabil Circuit (JBL) to Sector Perform from Outperform. As reasons for the downgrade, the firm cited concerns about Jabil circuit's largest customer, Apple (AAPL), as well as its belief that Jabil's FY15 guidance appears to reflect a best-case scenario. Target to $20 from $21.
07:46 EDTAAPLApple to add call credit payments in China, Marbridge Daily says
Subscribe for More Information
07:21 EDTMRKFDA Pediatric Advisory Committee to hold a meeting
The Committee discusses pediatric-focused safety reviews including MDT's Activa Dystonia Therapy, (BAX's Advate and Tisseel, NVS' Famvir, Tibotec's (JNJ subsidiary) Intelence, UCB Pharma's Keppra, MRK's Maxalt, BAYRY's Natazia, Digestive Care's Pertzye, JNJ's Prezista, BMY's Reyataz, SNY's Sklice, PFE's Torisel, Aptalis' Ultresa, and GILD's Viread in a meeting being held in Bethesda, Maryland on April 21 at 8 am. Webcast Link
06:51 EDTBACNYSE, BofA among those sued regarding high-frequency trading, Bloomberg says
Subscribe for More Information
06:48 EDTAAPLMicrosoft faces internal & external conflicts in three segments, DigiTimes says
Subscribe for More Information
06:45 EDTAAPLApple and Google compete to offer exclusive game apps, WSJ reports
Subscribe for More Information
06:37 EDTAAPLSquare discusses possible sale as losses widen, WSJ reports
Mobile-payments startup Square discussed a possible sale to several rivals as its losses widen, reports the Wall Street Journal, citing people familiar with the matter. Google (GOOG) discussed a possible acquisition of the company earlier this year, but it was not clear if the talks were continuing. Square also had discussions about a deal with Apple (AAPL) and eBay's (EBAY) PayPal. Reference Link
06:27 EDTAAPLApple revenue outlook likely to miss expectations, says Piper Jaffray
Subscribe for More Information
06:26 EDTAAPLCourt documents say Silicon Valley giants discussed hiring, WSJ says
Google (GOOG), Apple (AAPL), Intel (INTC) and Adobe (ADBE had colluded with one another to supress wages between 2005 and 2009, reports the Wall Street Journal, citing documents from an antitrust case. The companies had agreed not to poach each other's employees among other things. The companies had also tried to bring Facebook (FB) on board, but Facebook rejected the offer. Reference Link
April 19, 2014
11:12 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
April 17, 2014
16:45 EDTBACMarket swings to gains in holiday-shortened week
Subscribe for More Information
13:50 EDTMRKFDA approves Ragwitek for short ragweed pollen allergies
Subscribe for More Information
09:59 EDTBACOn The Fly: Analyst Upgrade Summary
Subscribe for More Information
09:35 EDTAAPLActive equity options trading on open
Active equity options trading on open according to Track Data: AAPL GOOGL GOOG NFLX TSLA AMZN GOLG NOV AA IBM
07:32 EDTBACBank of America upgraded at Oppenheimer
Subscribe for More Information
07:21 EDTAAPLApple April weekly volatility elevated at 38 into Q2
Subscribe for More Information
06:55 EDTAAPLApple plans to launch song-ID feature for iOS software, Bloomberg says
Subscribe for More Information
06:44 EDTBACBank of America to pay $950M to settle mortgage allegations, NY Times says
Subscribe for More Information
06:31 EDTBACBig banks boosting their business lending, WSJ reports
Subscribe for More Information
06:28 EDTBACBank of America upgraded to Outperform from Perform at Oppenheimer
Subscribe for More Information
April 16, 2014
17:57 EDTAAPLYahoo seeks default search status for Apple products, Re/code says
Subscribe for More Information
17:28 EDTBACBank of America still a buy, Barron's says
Subscribe for More Information
16:40 EDTBACOn The Fly: Closing Wrap
Stocks on Wall Street were higher after Fed Chair Janet Yellen struck a dovish tone in comments to the Economic Club of New York, which was in step with the minutes of the last FOMC meeting released last week. The Fed also released its latest Beige Book report, which indicated that economic activity increased in most regions after the severe winter weather that gripped much of the country to start the year had let up. Corporate earnings season continues to pick up steam, with Dow members IBM (IBM) and American Express (AXP), as well as Google (GOOG), reporting after the market close. ECONOMIC EVENTS: In the U.S., housing starts in March were up 2.8% from the prior month to a rate of 946K, versus expectations for an increase of 7%. Building permits were down 2.4% to a 990K rate, versus expectations for a decline of 0.4%. Industrial production rose 0.7% in March, which was ahead of the 0.5% forecast. The Fed's Beige Book report indicated that economic activity rebounded and strengthened in most regions over the last six week. In China, data showed its economy grew 7.4% in the first quarter from a year earlier, providing relief after recent signs that growth in the world's second largest economy has been slowing. COMPANY NEWS: Bank of America (BAC) fell 26c, or 1.59%, to $16.13 after the bank reported a first quarter loss of 5c per share, largely due to $6B in legal charges. Excluding the impact of this litigation expense, which was related to a previously announced settlement with the Federal Housing Finance Agency and other legacy mortgage-related matters, the banking major reported earnings that appeared to beat estimates... Yahoo (YHOO) gained $2.14, or 6.26%, to $36.35 after its quarterly report, with investors reacting most positively to the 66% year-over-year revenue growth reported by Chinese e-commerce company Alibaba, in which Yahoo holds a 24% stake. Yahoo's quarterly profit and revenue also beat expectations and the company's CEO Marissa Mayer said during its earnings webcast that the search giant's core business has moved from declining growth to stable to modest growth. MAJOR MOVERS: Among the notable gainers was CBS Outdoor (CBSO), which jumped $1.94, or 6.69%, to $30.96 after the IRS approved a plan for the company, which was just last week spun-off from its parent CBS (CBS), to convert into a real estate investment trust, or REIT. Other companies seeking REIT status, including Equinix (EQIX), Iron Mountain (IRM) and Lamar Advertising (LAMR), also rose following CBS' announcement. Also higher was drugmaker Zogenix (ZGNX), up 48c, or 20.51%, to $2.82 after confirming that a judge prevented a ban on sales of the company's Zohydro pain medication in Massachusetts. Among the noteworthy losers were U.S.-listed shares of Credit Suisse (CS), which fell 54c, or 1.7%, to $31.22 after the Swiss bank reported net income and revenue that fell when compared to the prior year. Also lower were Agnico Eagle Mines (AEM) and Yamana Gold (AUY) after agreeing to jointly acquire Osisko Mining. Angico shares fell $2.61, or 8.56%, to $27.88, while Yamana was down 36c, or 4.3%, to $8.02. INDEXES: The Dow was up 162.29, or 1.0%, to 16,424.85, the Nasdaq was up 52.06, or 1.29%, to 4,086.23, and the S&P 500 was up 19.33, or 1.05%, to 1,862.31.
16:00 EDTAAPL, BACOptions Update; April 16, 2014
Subscribe for More Information
14:42 EDTBACBofA in mortgage settlement talks with DOJ, multiple AGs, WSJ says
Subscribe for More Information
12:47 EDTBACOn The Fly: Midday Wrap
Stocks on Wall Street were higher at midday as the earnings season picks up steam. Stocks began the session sharply higher, with the market attempting to extend the rally that began on Monday. The move upward comes in spite of the dayís housing data coming in below expectations. This afternoon, investors will be watching the Fedís Beige Book report in hopes it provides evidence that the economy is strengthening. ECONOMIC EVENTS: In the U.S., housing starts in March were up 2.8% from the prior month to a rate of 946K, versus expectations for an increase of 7%. Building permits were down 2.4% to a 990K rate, versus expectations for a decline of 0.4%. Industrial production rose 0.7% in March, which was ahead of the 0.5% forecast. The Fedís Beige Book report, which includes anecdotal reports on business conditions in the various Fed districts, is due out at 2:00 pm ET. In China, data showed its economy grew 7.4% in the first quarter from a year earlier, providing relief after recent signs that growth in the world's second largest economy has been slowing. COMPANY NEWS: Shares of Bank of America (BAC) were down over 2% near midday after the company reported a first quarter loss of 5c per share, which was influenced by $6B in legal charges. The $6B in litigation expense, which was related to a previously announced settlement with the Federal Housing Finance Agency and added reserves for other legacy mortgage-related matters, hurt the banks earnings by about 40c per share... Yahoo (YHOO) rose more than 6% after reporting first quarter profit and sales last night that beat expectations. A great deal of attention was also paid to the 66% year-over-year increase in revenue reported by Alibaba, the Chinese group of e-commerce sites in which Yahoo has a 24% stake. This morning, Wells Fargo upgraded its rating on Yahoo to Outperform from Market Perform and raised its price target range for shares to $45-$47 from $38-$40, while Jefferies assumed coverage of Yahoo and also raised its rating on the stock. MAJOR MOVERS: Among the notable gainers was SodaStream (SODA), which surged 9% after an Israeli website said that the company was in talks to sell a 10% or greater stake to a big name company such as PepsiCo (PEP), Dr Pepper Snapple (DPS), or Starbucks (SBUX). Also higher was drugmaker Zogenix (ZGNX), which gained nearly 10% after confirming that a judge prevented a ban on sales of the company's Zohydro pain medication in Massachusetts. Among the noteworthy losers was Agnico Eagle Mines (AEM), which fell 7.5% after agreeing to jointly acquire Osisko Mining in partnership with Yamana Gold (AUY). Yamana shares were also down 3%. Also lower following their earnings reports were ADTRAN (ADTN), which fell nearly 6%, and CSX (CSX), which dropped about 3%. INDEXES: Near midday, the Dow was up 124.14, or 0.76%, to 16,386.70, the Nasdaq was up 37.86, or 0.94%, to 4,072.02, and the S&P 500 was up 13.52, or 0.73%, to 1,856.50.
11:40 EDTBACBank of America management to meet with Jefferies
Meeting to be held in Boston on April 22 hosted by Jefferies.
11:02 EDTAAPLApple slips lower, levels to watch
Subscribe for More Information
10:11 EDTBACBank of America falls after results, levels to watch
Shares are trading near the session low at $15.82 following earnings. At that price next support is at $15.18. Resistance is at $16.20.
09:36 EDTBAC, AAPLActive equity options trading on open
Subscribe for More Information
09:11 EDTBACBofA sees being in better position in Q2 compared to start of the year
Subscribe for More Information
08:52 EDTBACBank of America still sees 'New BAC' quaterly savings of $2.0B by mid-2015
Subscribe for More Information
08:46 EDTAAPLApple risk/reward looks positive into Q2 results, says Pacific Crest
Pacific Crest thinks that Apple's low valuation should prevent it from falling sharply, and it expects the company's Q2 iPhone sales to exceed expectations. The firm believes that iPhone 6 can enable the company to return to growth, and recommends buying the stock. .
08:35 EDTAAPLLiveDeal completes development of iOS mobile app
Subscribe for More Information
07:51 EDTAAPLApple denied motion to dismiss e-books suit, Reuters says
Subscribe for More Information
07:45 EDTAAPLApple earnings have more downside risk than upside risk, says Bernstein
Subscribe for More Information
07:40 EDTAAPLGoogle Play Q1 downloads exceeded downloads from Apple store, App Annie says
Subscribe for More Information
07:11 EDTBACBank of America reports book value per share $20.75 at March 31
Tangible book value per share was $13.81 at March 31, compared to $13.79 at December 31, 2013 and $13.36 at March 31, 2013. Book value per share was $20.75 at March 31, compared to $20.71 at December 31, 2013 and $20.19 at March 31, 2013.
07:10 EDTBACBank of America estimates Basel 3 Standard common tier 1 capital ratio 9.3%
Subscribe for More Information
07:07 EDTBACBank of America says Q1 earnings hurt by resolving more mortgage issues
Subscribe for More Information
07:05 EDTBACBank of America reports Q1 provision for credit losses $1.01B
Subscribe for More Information
07:03 EDTBACBank of America reports Q1 EPS ex-items 35c, consensus 27c
Subscribe for More Information
06:52 EDTAAPLSamsung objects to Apple's patent claims in $2B court battle, Bloomberg says
Subscribe for More Information
April 15, 2014
16:00 EDTAAPLOptions Update; April 15, 2014
Subscribe for More Information
15:25 EDTBACBank of America April 16 straddle priced for 3.3% move
Subscribe for More Information
15:19 EDTBACNotable companies reporting before tomorrow's open
Subscribe for More Information
13:06 EDTBACEarnings Preview: Analysts lukewarm on Bank of America into Q1 results
Subscribe for More Information
12:01 EDTBACFirst Majestic announces $30M forward sale contract on lead production
First Majestic (AG) announced that it has entered into a $30M forward sale contract with Bank of America (BAC) Merrill Lynch on a portion of the company's future lead production. The company executed this forward sale contract for 15,911.3 metric tonnes of lead at a fixed price of $0.945 per pound for total proceeds of $30M. The contract term is valid from April to September 2017, with a six-month repayment holiday from April to September. The forward sale contract is financially settled from the sale of lead from any of First Majestic's operations and represents approximately 35% of the company's total estimated future lead production over this period. The purpose of this prepayment contract is to fund the Company's continuing expansion plans and for general working capital.
10:25 EDTBACBank of America reports March default rate 3.55% vs. 3.53% last month
Reports March delinquency rate 2.18% vs. 2.26% last month.
09:35 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:23 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
08:19 EDTMRKLeerink's pharma and biotech analysts hold an analyst/industry conference call
Subscribe for More Information
07:46 EDTAAPLMonitor says Apple antitrust compliance off to 'promising start,' Reuters says
Subscribe for More Information
07:28 EDTBACBofA/Merrill's to hold a breakfast meeting
Subscribe for More Information
06:32 EDTMRKPatients paying much more for specialty drugs, NY Times says
The amount that patients with certain diseases must pay for specialty drugs has increased significantly, a research firm reported, according to The New York Times. Meanwhile, consumers' use of health care increased in 2013 for the firm time in three years, the newspaper quoted the firm, the IMS Institute for Healthcare Informatics, as saying. Publicly traded drug makers include AstraZeneca (AZN), Bristol-Myers (BMY), Eli Lilly (LLY), GlaxoSmithKline (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY). Publicly traded health insurers include AMERIGROUP (AGP), Aetna (AET), Centene (CNC), Cigna (CI), Health Net (HNT), Healthspring (HS), Humana (HUM), Molina Healthcare (MOH), UnitedHealth (UNH), WellCare (WCG) and WellPoint (WLP).Reference Link
06:08 EDTAAPLSamsung: Gains in smartphone market the result of strategy shift, WSJ reports
Subscribe for More Information
April 14, 2014
18:00 EDTMRKU.S. FDA approves Merck's GRASTEK
Subscribe for More Information
16:00 EDTBAC, AAPLOptions Update; April 14, 2014
iPath S&P 500 VIX Short-Term Futures down 32c to 44.41. Option volume leaders: AAPL C GILD TSLA LNG NQ BAC ZNGA according to Track Data.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
07:54 EDTAAPLApple in talks for $100 iPhone 6 price increase, says Jefferies
Subscribe for More Information
07:06 EDTAAPLU.S. Geospatial Intelligence Foundation to hold a symposium
GEOINT 2013 Symposium, originally scheduled for October 2013, is being held in Tampa, Florida on April 14-17.
06:50 EDTAAPLChecks show Apple not developing basebands, says Deutsche Bank
Deutsche Bank says that despite recent press reports, its industry checks show that Apple (AAPL) is not developing its own baseband chipset. Deutsche believes Apple likely seeking better integration with existing baseband chipsets or possibly developing its own internal WiFi chipset. The firm thinks Qualcomm's (QCOM) long term prospects remain intact and it reiterates a Buy rating on the stock with an $86 price target.
06:40 EDTAAPLNo lines for Samsung's Galaxy S5 but carriers say demand healthy, Re/code says
Subscribe for More Information
06:11 EDTAAPLIntel works with HzO to enhance water resistance in products, DigiTimes says
Subscribe for More Information
06:08 EDTMRKMerck volatility elevated into Q1 and outlook
Subscribe for More Information
April 11, 2014
12:12 EDTAAPLApple April weekly volatility elevated at 34 into Q2
Apple 4/25/14 weekly call option implied volatility is at 34, May is at 25, June is at 23, October at 21; compared to its 26-week average of 26 according to Track Data, suggesting large near term price movement into the expected release of Q2 results on April 23.
10:19 EDTAAPLApple drops to session lows, levels to watch
Subscribe for More Information
09:37 EDTBAC, AAPLActive equity options trading on open
Subscribe for More Information
08:38 EDTBACBank of America April volatility elevated into Q1 and revenue growth outlook
Subscribe for More Information
08:02 EDTAAPLApple Q1 should be in line but slight risk to Q2, says Cowen
Subscribe for More Information
06:47 EDTAAPLSamsung ups S5 incentives to fend off rivals, Bloomberg says
Subscribe for More Information
06:46 EDTAAPLDocuments: Samsung misled investors about Galaxy tablet sales, Fotune says
According to documents revealed in the Samsung (SSNLF)-Apple (AAPL) lawsuit, Samsung misled the public about how many tablets it sold in 2011, Fortune reports. Strategy Analytics told the world Samsung sold 2M Galaxy Tablets in six weeks, when "it took Samsung all of 2011 to sell half that many." Reference Link
06:28 EDTAAPLApple: iOS, OSX not affected by Heartbleed flaw, Re/code reports
Subscribe for More Information
06:05 EDTAAPLReport: Apple may offer high-res iTunes tracks in 2 months, Apple Insider says
Apple may plan to offer high-resolution 24-bit tracks on iTunes some time in the next few months, reports Apple Insider. Blogger Robert Hutton, citing an unnamed source, said Apple will charge an additional dollar for the high-resolution tracks. Reference Link
05:22 EDTMRKMerck says Hepatitis C combination therapy shows antiviral activity
Subscribe for More Information
April 10, 2014
17:44 EDTMRKMerck stock could return 20%, Barron's says
Subscribe for More Information
16:00 EDTAAPLOptions Update; April 10, 2014
Subscribe for More Information
11:21 EDTBACBank of America falls to important support area, levels to watch
Subscribe for More Information
10:00 EDTAAPLOn The Fly: Analyst Initiation Summary
Apple (AAPL) initiated with a Buy at Deutsche Bank... Crocs (CROX) initiated with a Buy at Buckingham... Deckers Outdoor (DECK) initiated with a Buy at Buckingham... EMC (EMC) initiated with a Buy at Deutsche Bank... HP (HPQ) initiated with a Buy at Deutsche Bank... IBM (IBM) initiated with a Hold at Deutsche Bank... NeoPhotonics (NPTN) coverage resumed with a Market Perform at Raymond James... NetApp (NTAP) initiated with a Hold at Deutsche Bank... Nutrisystem (NTRI) initiated with a Buy at B. Riley... Questar (STR) initiated with an Underperform at BofA/Merrill... S&T Bancorp (STBA) initiated with an Outperform at Raymond James... STB Systems Inc (STBI) initiated with an Outperform at Raymond James... Skechers (SKX) initiated with an Underperform at Buckingham... Steven Madden (SHOO) initiated with a Buy at Buckingham... UGI Corporation (UGI) initiated with a Buy at BofA/Merrill... Web.com (WWWW) initiated with a Neutral at Buckingham... Ally Financial (ALLY) initiated with a Buy at BTIG... Visteon (VC) initiated with a Buy at Citigroup... Greatbatch (GB) initiated with a Buy at KeyBanc... Steris (STE) initiated with a Buy at KeyBanc... Cooper Companies (COO) initiated with a Hold at KeyBanc... Hill-Rom (HRC) initiated with a Hold at KeyBanc... Invacare (IVC) initiated with a Hold at KeyBanc... Teleflex (TFX) initiated with a Hold at KeyBanc... Provident Financial (PROV) initiated with a Market Perform at Keefe Bruyette... UMH Properties (UMH) initiated with a Hold at Wunderlich.
09:37 EDTMRK, AAPLActive equity options trading on open
Active equity options trading on open according to Track Data: SIRI RAD AAPL AMZN AA FB TSLA MRK CVX C
09:21 EDTMRKOn The Fly: Pre-market Movers
Subscribe for More Information
08:22 EDTAAPLApple seen offering iWatches priced as high as 'thousands,' AppleInsider says
KGI analyst Ming-Chi Kuo, who has a proven track record of predicting about Apple hardware, predicts that one of the major differences between Apple's smartwatch and those from rivals will be that its casing and band will come in a variety of materials and that luxury iWatches will carry a price tag of "several thousand dollars," reported AppleInsider. Other features expected by Kuo for the device, including biometrics, a flexible AMOLED display with sapphire cover lens and NFC, the report added. Reference Link
08:03 EDTMRKXencor Merck receives milestone payment from Merck for using XmAb antibody
Xencor (XNCR) announced that the company has received a milestone payment from Merck (MRK), through a subsidiary, triggered by the initiation of a Phase 1 clinical trial for an undisclosed biologic drug candidate that uses Xencor's XmAb antibody engineering intellectual property. Under the terms of the agreement signed in June 2013, Xencor granted Merck a non-exclusive license to certain Xencor patents for use in an undisclosed product, as well as an option to license the same intellectual property for future products. Xencor received an upfront payment and continues to receive annual maintenance fees. Xencor is also eligible to receive milestone payments associated with the successful development of Merck product candidates, as well as royalties on sales of any potential products that may result from this agreement.
07:39 EDTAAPLApple Chief Designer gains more say over software, Bloomberg says
Subscribe for More Information
07:24 EDTAAPLApple may release 12" Retina MacBook Air, low price iMac in 2014, MacRumors says
Subscribe for More Information
06:48 EDTAAPLApple initiated with a Buy at Deutsche Bank
Deutsche Bank believes the iPhone and iPad offer good growth for Apple with upside coming from the potential for a larger screen sized phone. The firm initiated the stock with a Buy rating and $650 price target.
06:41 EDTAAPLApple confirms Christie departure, FT reports
Subscribe for More Information
06:35 EDTBACMobile banking presents opportunity and risks for banks, WSJ reports
Subscribe for More Information
05:27 EDTMRKMerck announces data from C-WORTHy study
Merck announced additional data from the ongoing C-WORTHy study, a multi-arm Phase 2 clinical trial evaluating the efficacy and safety of a once-daily, all-oral regimen combining MK-5172, an investigational hepatitis C virus, or HCV, NS3/4A protease inhibitor, and MK-8742, an investigational HCV NS5A replication complex inhibitor, among patients with chronic HCV Genotype 1 infection, or GT1. In an interim analysis of treatment-naÔve, non-cirrhotic patients administered a 12-week regimen of MK-5172/MK-8742, with and without ribavirin, or RBV, a sustained viral response, or SVR, was observed in 98% of patients administered MK-5172/MK-8742 alone and 94% in those administered MK-5172/MK-8742 plus RBV.
April 9, 2014
17:26 EDTAAPLGartner says worldwide PC shipments in Q1 fell 1.7%
Subscribe for More Information
16:00 EDTAAPLOptions Update; April 9, 2014
Subscribe for More Information
15:56 EDTAAPLApple interface head rumored to be exiting, AppleInsider says
Subscribe for More Information
15:21 EDTAAPLApple weighing 'dramatic' overhaul of iTunes store, Billboard says
Subscribe for More Information
13:37 EDTBACBank of America ordered by CFPB to pay $727M for illegal credit card practices
Subscribe for More Information
12:24 EDTBACBank of America to pay $800M in credit card settlement, WSJ says
Subscribe for More Information
11:43 EDTMRKGilead defended by analysts after recent pullback
Subscribe for More Information
10:39 EDTAAPLJudge says certain WiLAN patent claims are valid in litigation vs. Apple
Subscribe for More Information
10:39 EDTAAPLLogitech has risk of increasing competition from Apple, says UBS
UBS notes that Apple (AAPL) filed a patent with the USPTO for an electronic device/tablet cover that seems to include a keyboard. UBS believes Apple could introduce its own branded keyboard cover, and other branded peripherals, in order to grab market share from its highly loyal consumer base. The analyst believes competition for Neutral rated Logitech (LOGI) will accelerate, significantly impacting growth prospects.
09:36 EDTAAPLActive equity options trading on open
Subscribe for More Information
08:48 EDTBACHuntington Bancshares to acquire 11 branches in central, east Michigan
Subscribe for More Information
08:24 EDTAAPLGoogle, Apple have considered acquiring Square, Re/code reports
Subscribe for More Information
07:54 EDTAAPLSamsung, Apple pushed to make high-end phones less costly, Reuters says
Subscribe for More Information
07:41 EDTBACBofA unit, Allstate dismiss toxic mortgage debt suit, Reuters says
Allstate (ALL) and Bank of America's (BAC) Countrywide unit have agreed to end a lawsuit stemming from $700M of toxic mortgage debt, according to Reuters, citing a court filing. Reference Link
07:28 EDTAAPLAmazon looking to court game developers for Fire TV, NY Post reports
Subscribe for More Information
07:23 EDTMRKEuropean Association for the Study of the Liver to hold annual meeting
Subscribe for More Information
07:09 EDTMRKReckitt Benckiser may be frontrunner for Merck unit, Bloomberg reports
Subscribe for More Information
07:00 EDTBACBofA, Intel fire 3K workers, leaving Costa Rica shocked, Bloomberg says
Subscribe for More Information
06:35 EDTBACRegulators increase leverage ratio requirement for large banks, NY Times says
Subscribe for More Information
06:27 EDTBACBig banks must add capital to comply with new rules, WSJ reports
A of January 1, 2018, the U.S.'s eight largest banks -- including Citigroup (C), JPMorgan (JPM) and Goldman Sachs (GS) -- must add up to $68B in extra capital to comply with a new rule intended to help firms weather losses during periods of market stress, the Wall Street Journal. The banks will be required to maintain well above the minimum levels of capital held against assets on their books. Banks must report the new levels next year. Reference Link
06:18 EDTAAPLApple seeks $2.2B in damages from Samsung in patent infringement, WSJ says
Subscribe for More Information
06:15 EDTAAPLFlexible PCB samples delivered for Apple iWatch validation, DigiTimes says
Flexible PCB suppliers have reportedly delivered FPCB samples for use in Apple's iWatch devices for validation, reports DigiTimes. According to industry sources, Apple is expected to unveil the iWatch wearable devices in September. Reference Link
<< 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use